Future-Proofing A Volatile Supply Chain Through Modular Biomanufacturing

By Rasmus Pedersen, Ph.D., Associate Director, Process Technology, John Stewart, Vice President, kojoX Strategy, and Peter Skals, Head of Global Sustainability, FUJIFILM Biotechnologies

Biopharmaceutical supply chains are more unpredictable than ever, even as drug companies increasingly rely on outsourcing. To navigate this challenging landscape, contract development and manufacturing organizations (CDMOs) need to focus on strong sourcing strategies and proactive vendor management.

The kojoX ecosystem, developed by FUJIFILM Biotechnologies, is a game changer for biologics development and manufacturing. By integrating modularization and standardization, kojoX reduces supply chain risks while boosting flexibility, scalability, and resilience.

Through a commitment to continuous innovation, strategic investment, and long-term partnerships, kojoX is reshaping the industry. It's building a more agile and futureproofed biomanufacturing ecosystem.